Antares Pharma, Inc.: Marketing Products with Efficacy and Safety

As a specialty pharmaceutical company, Antares Pharma, Inc. continues to provide the world with products that intend to enhance safety and efficacy of medications. Through these items, the administration of therapeutics is controlled and instances of overdosing and instances of side effects are reduced.

There are three proprietary platforms that the company is developing and two of these products have already received approval from the Food and Drug Administration for commercialization. Two of the injectable products that the company is commercializing are the OTREXUP and Tjet/Zomajet. The former is intended for use on patients with rheumatoid arthritis and psoriasis and the latter is a needle free injector, which is used to deliver growth hormone. The topical gels marketed by the company are the Gelnique and Elestrin.

It was in 1979 that the company started its operations. Today, the business is headquartered in Ewing, New Jersey and continues to supply the world with efficient and subcutaneous injection technology platforms.